AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (February 26, 2002). doi:10.1152/ajprenal.00347.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/2/F294    most recent
00347.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hocherl, K.
Right arrow Articles by Kurtz, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hocherl, K.
Right arrow Articles by Kurtz, A.

Articles in PresS, published online ahead of print February 25, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00347.2001
Submitted on November 27, 2001
Accepted on February 8, 2002

Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake

Klaus Hocherl1*, Martin Kammerl2, Karl Schumacher3, Dirk Endemann2, Horst F Grobecker1, and Armin Kurtz4

1 Institut fur Pharmakologie, Universitat Regensburg, Regensburg, Germany
2 Innere Medizin II, Universitatsklinikum Regensburg, Regensburg, Germany
3 Institut fur Anatomie, Universitat Regensburg, Regensburg, Germany
4 Institut fur Physiologie, Universitat Regensburg, Regensburg, Germany

* To whom correspondence should be addressed. E-mail: klaus.hoecherl{at}chemie.uni-regensburg.de.

We investigated the impact of cyclooxygenase (COX) activity for the regulation of the renin-angiotensin-aldosterone system by salt intake. Therefore, Sprague-Dawley rats were subjected to different salt diets (0.02%, 0.6% and 8% NaCl, wt/wt) and treated with the selective COX-2 inhibitor rofecoxib (10 mg/kg x d) or with ketorolac at a dose selective for COX-1 inhibition (2 mg/kg x d) for 3, 7, 14 and 21 days. Rofecoxib and Ketorolac caused a similar reduction of renocortical prostaglandin E2 (PGE2) formation with low salt diet. Rofecoxib did not change plasma renin activity (PRA) nor renocortical renin mRNA abundance at any salt diet, but clearly lowered plasma aldosterone concentration (PAC). In contrast, Ketorolac delayed the increase of PRA and of renin mRNA in response to low salt intake but did not change PAC. Prolonged treatment with rofecoxib but not with ketorolac caused an upregulation of COX-2 expression whilst COX-1 mRNA abundance remained unchanged. These findings suggest that COX-1 but not COX-2 derived prostanoids are of relevance for the regulation of the renin system by salt intake.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Sankaran, N. Bankovic-Calic, M. R. Ogborn, G. Crow, and H. M. Aukema
Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F821 - F830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Matzdorf, A. Kurtz, and K. Hocherl
COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1782 - F1790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. M. Kim, L. Chen, D. Mizel, Y. G. Huang, J. P. Briggs, and J. Schnermann
Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F415 - F422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. A. Kocks, S. Gschwend, D. de Zeeuw, G. Navis, and H. Buikema
Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1183 - 1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. J. Swenson, R. C. Speth, and J. P. Porter
Effect of a perinatal high-salt diet on blood pressure control mechanisms in young Sprague-Dawley rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R764 - R770.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Stauss
Interaction of prostaglandins with the renin-angiotensin system
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1010 - R1011.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Schweda, C. Wagner, B. K. Kramer, J. Schnermann, and A. Kurtz
Preserved macula densa-dependent renin secretion in A1 adenosine receptor knockout mice
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F770 - F777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.